<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Arq Bras Cardiol</journal-id>
      <journal-id journal-id-type="iso-abbrev">Arq. Bras. Cardiol</journal-id>
      <journal-id journal-id-type="publisher-id">Arq. Bras. Cardiol.</journal-id>
      <journal-title-group>
        <journal-title>Arquivos Brasileiros de Cardiologia</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0066-782X</issn>
      <issn pub-type="epub">1678-4170</issn>
      <publisher>
        <publisher-name>Sociedade Brasileira de Cardiologia</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">24343555</article-id>
      <article-id pub-id-type="pmc">4081174</article-id>
      <article-id pub-id-type="doi">10.5935/abc.20130220</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Anatomopathological Session</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Case 5 - A 73 Year-Old Man with Heart Failure, Preserved Systolic
Function and Associated Renal Failure</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Politi</surname>
            <given-names>Tiago Rodrigues</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Gutierrez</surname>
            <given-names>Paulo Sampaio</given-names>
          </name>
        </contrib>
        <aff> Instituto do Cora&#xE7;&#xE3;o (InCor) HC-FMUSP, S&#xE3;o Paulo, SP - Brazil</aff>
      </contrib-group>
      <author-notes>
        <corresp id="c01"><bold>Mailing Address: Vera Demarchi Aiello</bold>, bloco I, Cerqueira C&#xE9;sar. Postal
Code 05403-000, S&#xE3;o Paulo, SP - Brazil. E-mail: <email>demarchi@cardiol.br</email>,
<email>vera.aiello@incor.usp.br</email></corresp>
      </author-notes>
      <pub-date pub-type="ppub">
        <month>11</month>
        <year>2013</year>
      </pub-date>
      <volume>101</volume>
      <issue>5</issue>
      <fpage>e86</fpage>
      <lpage>e94</lpage>
      <permissions>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">
          <license-p>This is an Open Access article distributed under the terms of the Creative
Commons Attribution Non-Commercial License which permits unrestricted
non-commercial use, distribution, and reproduction in any medium, provided the
original work is properly cited. </license-p>
        </license>
      </permissions>
      <kwd-group>
        <kwd>Heart Failure</kwd>
        <kwd>Renal Insufficiency</kwd>
        <kwd>Pulmonary Embolism</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <p>Male patient, 73 years old, retired metallurgist, born in Alagoas, residing in Sao Paulo,
sought medical attention for dyspnea on minimal exertion.</p>
    <p>At his first visit to Instituto do Cora&#xE7;&#xE3;o - Incor (18/June/2004) he complained of dyspnea
that had begun 28 years before, initially triggered by great exertion; however, in the last
two years it had progressed to dyspnea at minimal exertion and for the last month, it
occurred even at rest and with orthopnea. These symptoms showed slight improvement with
furosemide and digoxin.</p>
    <p>He also reported chest pain on exertion, accompanied by sweating and nausea for the last
five years before that consultation. The patient underwent a coronary angiography, which
showed a 40% lesion in the anterior descending and first diagonal arteries and 50% lesion
in the right coronary artery. The left ventricle was normal, with hypertrophic appearance,
and he had pulmonary artery hypertension (systolic pressure of 50 mmHg).</p>
    <p>The patient denied current smoking, alcohol consumption, arterial hypertension,
dyslipidemia and diabetes mellitus. He underwent gastrectomy for peptic ulcer at 43 years
of age and reported anemia requiring blood transfusion a month before.</p>
    <p>He had a history of alteration in bowel movement with alternating diarrhea and constipation
since the age of 69 and had lost 12 kg in recent months.</p>
    <p>Physical examination showed a patient weighing 54.3 kg, height 1.68 m, BMI 19.2 kg /
m<sup>2</sup>, heart rate of 96 bpm, blood pressure 92 x 50 mmHg, jugular stasis + +/ 4
+ at 45&#xB0;. Pulmonary auscultation showed crackles at the bases; cardiac auscultation showed
muffled heart sounds and holosystolic murmur at the lower sternal border; the liver was
palpable three centimeters from the right costal margin and there was no edema or signs of
poor peripheral perfusion.</p>
    <p>Laboratory tests showed: potassium = 5.3 mEq/ L, sodium = 135 mEq / L, creatinine = 2.1
mg/dL, hemoglobin = 11.6 g/dL, hematocrit = 37%, leukocytes = 13,400 / mm <sup>3</sup> and
negative serology for Chagas disease.</p>
    <p>The ECG (June 15, 2004) showed sinus rhythm, 58 bpm HR, PR 220 ms, SAQRS (-) 20&#xB0;, dQRS 86
ms, QT 450 ms, first-degree atrioventricular block, ST depression in V<sub>5</sub> and
V<sub>6</sub> (with flattened or inverted T wave, suggestive of digitalis action) (<xref ref-type="fig" rid="f01">Figure 1</xref>). Chest x-ray showed + + / 4 +
cardiomegaly.</p>
    <fig id="f01" orientation="portrait" position="float">
      <label>Figure 1</label>
      <caption>
        <p>ECG &#x2013; Sinus rhythm, first-degree atrioventricular block, ST depression in V5 and V6
(flattened or inverted T wave, suggestive of digitalis action).</p>
      </caption>
      <graphic xlink:href="abc-101-05-0e86-g01"/>
    </fig>
    <p>The digoxin dose was decreased to 0.125 mg; the dose of 40 mg of furosemide was maintained
and 12.5 mg of hydrochlorothiazide were added, together with 40 mg of isosorbide and 100 mg
of acetylsalicylic acid daily.</p>
    <p>Echocardiography (May/2004) showed increased right and left atria, the latter measuring 48
mm, increased septal thickness (16 mm), normal left ventricular ejection fraction (66%) and
pulmonary hypertension (pulmonary artery systolic pressure = 65 mmHg).</p>
    <p>New laboratory tests were requested, as well as echocardiography, 24-hour Holter assessment
and myocardial perfusion scintigraphy. However, they were not performed because the patient
sought emergency medical care due to the persistence of dyspnea, onset of nausea and
vomiting and increased abdominal volume on July 7, 2004.</p>
    <p>Physical examination (July 07, 2004) showed the patient was in good general health status,
slightly pale, heart rate of 64 bpm, blood pressure 90 x 60 mmHg; crackles heard at the
lung bases; auscultation sounds were arrhythmic, no murmurs; abdomen: the liver was
palpable 5 cm below the costal margin, hardened, extending to the epigastrium; bowel sounds
were audible and there was no rebound tenderness; there was no lower-limb edema.</p>
    <p>Laboratory assessment (07/jul/2004) showed urea = 173 mg/dL, creatinine = 4.4 mg/dL,
potassium =5.9 mEq/L, hemoglobin = 11.1 g / dL, hematocrit = 34%, platelets =
284.000/mm<sup>3</sup>, leukocytes = 6.800/mm<sup>3</sup> , normal coagulation, troponin
= 0.82 ng/mL and CK-MB = 12.5 ng/mL. ECG (July 07, 2004) showed atrial fibrillation with
ventricular rate of 60 bpm, ST depression with flattened or inverted T wave, suggestive of
digitalis action (<xref ref-type="fig" rid="f02">Figure 2</xref>).</p>
    <fig id="f02" orientation="portrait" position="float">
      <label>Figure 2</label>
      <caption>
        <p>ECG &#x2013; Atrial fibrillation, with bradycardia, ST depression with flattened or inverted
T wave, suggestive of digitalis action.</p>
      </caption>
      <graphic xlink:href="abc-101-05-0e86-g02"/>
    </fig>
    <p>The diagnoses of heart failure, digitalis intoxication, chronic renal failure with acute
worsening of renal function and wasting syndrome were attained.</p>
    <p>Digoxin use was discontinued, with volume and dobutamine being administered.</p>
    <p>There was improvement in blood pressure, which increased to 100 x 60 mmHg, without
worsening of dyspnea, and creatine decrease. Dobutamine was discontinued on the
3<sup>rd</sup> day of hospitalization. The laboratory evolution is shown in <xref ref-type="table" rid="t01">Table 1</xref>.</p>
    <table-wrap id="t01" orientation="portrait" position="float">
      <label>Table 1</label>
      <caption>
        <p>Laboratory assessment during hospitalization</p>
      </caption>
      <table frame="hsides" rules="rows">
        <thead>
          <tr>
            <th rowspan="1" colspan="1">&#xA0;</th>
            <th rowspan="1" colspan="1">7/July</th>
            <th rowspan="1" colspan="1">13/July</th>
            <th rowspan="1" colspan="1">19/July</th>
            <th rowspan="1" colspan="1">21/July</th>
          </tr>
        </thead>
        <tbody>
          <tr>
            <td rowspan="1" colspan="1">Hemoglobin (g/dL)</td>
            <td align="center" rowspan="1" colspan="1">11,8</td>
            <td align="center" rowspan="1" colspan="1">8,5</td>
            <td align="center" rowspan="1" colspan="1">10,1</td>
            <td align="center" rowspan="1" colspan="1">8,9</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">Hematocrit (%)</td>
            <td align="center" rowspan="1" colspan="1">36</td>
            <td align="center" rowspan="1" colspan="1">26</td>
            <td align="center" rowspan="1" colspan="1">30</td>
            <td align="center" rowspan="1" colspan="1">28</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">MCV (pg)</td>
            <td align="center" rowspan="1" colspan="1">78</td>
            <td align="center" rowspan="1" colspan="1">81</td>
            <td align="center" rowspan="1" colspan="1">77</td>
            <td align="center" rowspan="1" colspan="1">82</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">Reticulocytes/mm<sup>3</sup></td>
            <td align="center" rowspan="1" colspan="1">-</td>
            <td align="center" rowspan="1" colspan="1">32.000</td>
            <td align="center" rowspan="1" colspan="1">-</td>
            <td align="center" rowspan="1" colspan="1">-</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">Leukocytes/mm<sup>3</sup></td>
            <td align="center" rowspan="1" colspan="1">7,100</td>
            <td align="center" rowspan="1" colspan="1">9,700</td>
            <td align="center" rowspan="1" colspan="1">5,800</td>
            <td align="center" rowspan="1" colspan="1">4,500</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">Neutrophils (%)</td>
            <td align="center" rowspan="1" colspan="1">88</td>
            <td align="center" rowspan="1" colspan="1">92</td>
            <td align="center" rowspan="1" colspan="1">60</td>
            <td align="center" rowspan="1" colspan="1">95</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">Rods (%)</td>
            <td align="center" rowspan="1" colspan="1">7</td>
            <td align="center" rowspan="1" colspan="1">0</td>
            <td align="center" rowspan="1" colspan="1">0</td>
            <td align="center" rowspan="1" colspan="1">0</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">Lymphocytes (%)</td>
            <td align="center" rowspan="1" colspan="1">7</td>
            <td align="center" rowspan="1" colspan="1">3</td>
            <td align="center" rowspan="1" colspan="1">2</td>
            <td align="center" rowspan="1" colspan="1">1</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">Monocytes (%)</td>
            <td align="center" rowspan="1" colspan="1">5</td>
            <td align="center" rowspan="1" colspan="1">5</td>
            <td align="center" rowspan="1" colspan="1">6</td>
            <td align="center" rowspan="1" colspan="1">4</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">Platelets/mm<sup>3</sup></td>
            <td align="center" rowspan="1" colspan="1">320,000</td>
            <td align="center" rowspan="1" colspan="1">188,000</td>
            <td align="center" rowspan="1" colspan="1">131,000</td>
            <td align="center" rowspan="1" colspan="1">105,000</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">Urea (mg/dL)</td>
            <td align="center" rowspan="1" colspan="1">170</td>
            <td align="center" rowspan="1" colspan="1">183</td>
            <td align="center" rowspan="1" colspan="1">250</td>
            <td align="center" rowspan="1" colspan="1">292</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">Creatinine (mg/dL)</td>
            <td align="center" rowspan="1" colspan="1">4.5</td>
            <td align="center" rowspan="1" colspan="1">3.7</td>
            <td align="center" rowspan="1" colspan="1">4.5</td>
            <td align="center" rowspan="1" colspan="1">5.5</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">Glucose (mg/dL)</td>
            <td rowspan="1" colspan="1">&#xA0;</td>
            <td align="center" rowspan="1" colspan="1">74</td>
            <td rowspan="1" colspan="1">&#xA0;</td>
            <td align="center" rowspan="1" colspan="1">67</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">Sodium (mEq/L)</td>
            <td align="center" rowspan="1" colspan="1">135</td>
            <td align="center" rowspan="1" colspan="1">135</td>
            <td align="center" rowspan="1" colspan="1">137</td>
            <td align="center" rowspan="1" colspan="1">139</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">Potassium (mEq/L)</td>
            <td align="center" rowspan="1" colspan="1">5.3</td>
            <td align="center" rowspan="1" colspan="1">5.5</td>
            <td align="center" rowspan="1" colspan="1">5.2</td>
            <td align="center" rowspan="1" colspan="1">5.7</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">Calcium (mEq/L0)</td>
            <td rowspan="1" colspan="1">&#xA0;</td>
            <td align="center" rowspan="1" colspan="1">4.38</td>
            <td rowspan="1" colspan="1">&#xA0;</td>
            <td rowspan="1" colspan="1">&#xA0;</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">Phosphorus (mg/dL)</td>
            <td rowspan="1" colspan="1">&#xA0;</td>
            <td align="center" rowspan="1" colspan="1">5.8</td>
            <td rowspan="1" colspan="1">&#xA0;</td>
            <td rowspan="1" colspan="1">&#xA0;</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">Magnesium (mEq/L0)</td>
            <td rowspan="1" colspan="1">&#xA0;</td>
            <td align="center" rowspan="1" colspan="1">2.55</td>
            <td rowspan="1" colspan="1">&#xA0;</td>
            <td rowspan="1" colspan="1">&#xA0;</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">Chloride (mEq/L)</td>
            <td rowspan="1" colspan="1">&#xA0;</td>
            <td align="center" rowspan="1" colspan="1">112</td>
            <td rowspan="1" colspan="1">&#xA0;</td>
            <td rowspan="1" colspan="1">&#xA0;</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">TSH (&#xB5;UI/mL)</td>
            <td rowspan="1" colspan="1">&#xA0;</td>
            <td align="center" rowspan="1" colspan="1">11.4</td>
            <td rowspan="1" colspan="1">&#xA0;</td>
            <td rowspan="1" colspan="1">&#xA0;</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">Free T4 (ng/dL0)</td>
            <td rowspan="1" colspan="1">&#xA0;</td>
            <td align="center" rowspan="1" colspan="1">0.7</td>
            <td rowspan="1" colspan="1">&#xA0;</td>
            <td rowspan="1" colspan="1">&#xA0;</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">AST (U/L)</td>
            <td rowspan="1" colspan="1">&#xA0;</td>
            <td align="center" rowspan="1" colspan="1">27</td>
            <td rowspan="1" colspan="1">&#xA0;</td>
            <td rowspan="1" colspan="1">&#xA0;</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">ALT (U/L)</td>
            <td rowspan="1" colspan="1">&#xA0;</td>
            <td align="center" rowspan="1" colspan="1">28</td>
            <td rowspan="1" colspan="1">&#xA0;</td>
            <td rowspan="1" colspan="1">&#xA0;</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">AF (U/L)</td>
            <td rowspan="1" colspan="1">&#xA0;</td>
            <td align="center" rowspan="1" colspan="1">329</td>
            <td rowspan="1" colspan="1">&#xA0;</td>
            <td rowspan="1" colspan="1">&#xA0;</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">Gamma GT (U/L)</td>
            <td rowspan="1" colspan="1">&#xA0;</td>
            <td align="center" rowspan="1" colspan="1">232</td>
            <td rowspan="1" colspan="1">&#xA0;</td>
            <td rowspan="1" colspan="1">&#xA0;</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">Amylase (U/L)</td>
            <td rowspan="1" colspan="1">&#xA0;</td>
            <td align="center" rowspan="1" colspan="1">65</td>
            <td rowspan="1" colspan="1">&#xA0;</td>
            <td rowspan="1" colspan="1">&#xA0;</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">DHL (U/L0)</td>
            <td rowspan="1" colspan="1">&#xA0;</td>
            <td align="center" rowspan="1" colspan="1">220</td>
            <td rowspan="1" colspan="1">&#xA0;</td>
            <td rowspan="1" colspan="1">&#xA0;</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">CRP (mg/L)</td>
            <td rowspan="1" colspan="1">&#xA0;</td>
            <td align="center" rowspan="1" colspan="1">28.4</td>
            <td rowspan="1" colspan="1">&#xA0;</td>
            <td rowspan="1" colspan="1">&#xA0;</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">Total bilirubins (mg/dL)</td>
            <td align="center" rowspan="1" colspan="1">0,72</td>
            <td align="center" rowspan="1" colspan="1">0.63</td>
            <td rowspan="1" colspan="1">&#xA0;</td>
            <td rowspan="1" colspan="1">&#xA0;</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">Direct bilirubin (mg/dL)</td>
            <td align="center" rowspan="1" colspan="1">0,26</td>
            <td align="center" rowspan="1" colspan="1">0.27</td>
            <td rowspan="1" colspan="1">&#xA0;</td>
            <td rowspan="1" colspan="1">&#xA0;</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">Total proteins (g/dL0)</td>
            <td rowspan="1" colspan="1">&#xA0;</td>
            <td align="center" rowspan="1" colspan="1">6.8</td>
            <td rowspan="1" colspan="1">&#xA0;</td>
            <td rowspan="1" colspan="1">&#xA0;</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">Albumin (g/dL)</td>
            <td rowspan="1" colspan="1">&#xA0;</td>
            <td align="center" rowspan="1" colspan="1">2.8</td>
            <td rowspan="1" colspan="1">&#xA0;</td>
            <td rowspan="1" colspan="1">&#xA0;</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">Cholesterol (mg/dL0)</td>
            <td rowspan="1" colspan="1">&#xA0;</td>
            <td align="center" rowspan="1" colspan="1">101</td>
            <td rowspan="1" colspan="1">&#xA0;</td>
            <td rowspan="1" colspan="1">&#xA0;</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">HDL-C (mg/dL0)</td>
            <td rowspan="1" colspan="1">&#xA0;</td>
            <td align="center" rowspan="1" colspan="1">42</td>
            <td rowspan="1" colspan="1">&#xA0;</td>
            <td rowspan="1" colspan="1">&#xA0;</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">LDL-C (mg/dL0)</td>
            <td rowspan="1" colspan="1">&#xA0;</td>
            <td align="center" rowspan="1" colspan="1">42</td>
            <td rowspan="1" colspan="1">&#xA0;</td>
            <td rowspan="1" colspan="1">&#xA0;</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">Triglycerides (mg/dL0)</td>
            <td rowspan="1" colspan="1">&#xA0;</td>
            <td align="center" rowspan="1" colspan="1">87</td>
            <td rowspan="1" colspan="1">&#xA0;</td>
            <td rowspan="1" colspan="1">&#xA0;</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">INR</td>
            <td rowspan="1" colspan="1">&#xA0;</td>
            <td align="center" rowspan="1" colspan="1">1.1</td>
            <td rowspan="1" colspan="1">&#xA0;</td>
            <td rowspan="1" colspan="1">&#xA0;</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">APTT (rel)</td>
            <td rowspan="1" colspan="1">&#xA0;</td>
            <td align="center" rowspan="1" colspan="1">0.95</td>
            <td rowspan="1" colspan="1">&#xA0;</td>
            <td rowspan="1" colspan="1">&#xA0;</td>
          </tr>
          <tr>
            <td colspan="5" rowspan="1">Venous gasometry</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">pH</td>
            <td rowspan="1" colspan="1">&#xA0;</td>
            <td rowspan="1" colspan="1">&#xA0;</td>
            <td align="center" rowspan="1" colspan="1">7.30</td>
            <td align="center" rowspan="1" colspan="1">7.29</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">pCO<sub>2</sub> (mm Hg)</td>
            <td rowspan="1" colspan="1">&#xA0;</td>
            <td rowspan="1" colspan="1">&#xA0;</td>
            <td align="center" rowspan="1" colspan="1">29</td>
            <td align="center" rowspan="1" colspan="1">44</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">pO<sub>2</sub> (mm Hg)</td>
            <td rowspan="1" colspan="1">&#xA0;</td>
            <td rowspan="1" colspan="1">&#xA0;</td>
            <td align="center" rowspan="1" colspan="1">37</td>
            <td align="center" rowspan="1" colspan="1">32</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">Sat O<sub>2</sub> (%)</td>
            <td rowspan="1" colspan="1">&#xA0;</td>
            <td rowspan="1" colspan="1">&#xA0;</td>
            <td align="center" rowspan="1" colspan="1">63.2</td>
            <td align="center" rowspan="1" colspan="1">47.6</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">HCO<sub>3</sub> (mEq/L)</td>
            <td rowspan="1" colspan="1">&#xA0;</td>
            <td rowspan="1" colspan="1">&#xA0;</td>
            <td align="center" rowspan="1" colspan="1">14</td>
            <td align="center" rowspan="1" colspan="1">20.5</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">Base excess (mEq/L)</td>
            <td rowspan="1" colspan="1">&#xA0;</td>
            <td rowspan="1" colspan="1">&#xA0;</td>
            <td align="center" rowspan="1" colspan="1">-11</td>
            <td align="center" rowspan="1" colspan="1">-5.4</td>
          </tr>
        </tbody>
      </table>
    </table-wrap>
    <p>Upper digestive endoscopy (July 20, 2011) showed esophageal tract of normal aspect, caliber
and extension and the gastroesophageal junction 40 cm above the upper arch showed no signs
of gastroesophageal reflux or hiatal hernia. In the distal third of the esophagus, there
were three fine caliber varicose veins, bluish, straight and without red spots. The stomach
showed good expandability and was reminiscent of the Billroth-II gastrectomy, having usual
proportions, with preserved pleated mucosa with no significant inflammatory reaction. There
were no changes in the anastomotic mouth and segments close to the afferent and efferent
loops. In conclusion, there were incipient esophageal varices; normal Billtoth II partial
gastrectomy and no hemorrhagic lesions.</p>
    <p>The abdominal ultrasonography (July 11, 2004) had disclosed an enlarged liver, with blunt
edges and heterogeneous texture with multiple nodular images with irregular borders;
ectasia of hepatic veins and inferior vena cava, with no signs of intrahepatic or
extrahepatic bile duct dilation and presence of voluminous ascites. The spleen was of
normal size. Kidney size was at the lower limit of normal dimensions (right kidney and left
kidney measured 8 cm and 9 cm, respectively), with more echogenic texture than the usual
and alteration in the corticomedullary ratio - 0.9 cm to the right and 0.9 cm to the left.
There were no calculi or hydronephrosis, but there were 1.7-cm simple cortical cysts in the
upper pole of the right kidney and smaller ones, of up to 0.8 cm, in the left kidney.</p>
    <p>Retroperitoneal visualization was not possible due to excessive intestinal gas.</p>
    <p>He received packed RBCs on July 13, 2004. On the 19<sup>th</sup>, he had abdominal
distension. On the afternoon of the 21<sup>st</sup>, he underwent CRA, resuscitated through
reanimation and defibrillation techniques; he was submitted to intubation and was
transferred from the Hospital Auxiliar de Cotox&#xF3; to Incor ER. The patient developed
bradycardia and shock, and after new CRA in asystole, he died at 1 AM on July 22, 2004.</p>
    <sec>
      <title>Clinical Aspects</title>
      <p>This is the case of a 73-year-old patient with hypothyroidism, coronary artery disease,
left ventricular hypertrophy, heart failure with preserved left ventricular ejection
fraction and exacerbation of chronic renal failure. The patient's clinical picture had
worsened in the last two years that preceded his last hospitalization, with progressive
symptom worsening.</p>
      <p>Among the possible causes for such clinical worsening, are: ischemic equivalent,
pulmonary thromboembolism and the evolution of the underlying disease, which in this
case corresponds to diastolic heart failure with preserved left ventricular ejection
fraction. As for the ischemic equivalent, the patient's episodes of chest pain were not
accompanied by typical manifestation of myocardial ischemic disease and additionally,
they did not trigger changes in the hemodynamic balance<sup><xref rid="r01" ref-type="bibr">1</xref></sup>. Furthermore, the patient had no predisposing risk
factors for coronary artery disease<sup><xref rid="r02" ref-type="bibr">2</xref></sup>
and the coronary angiography showed no significant coronary lesions. Thus, the
hypothesis of an ischemic event is weakened.</p>
      <p>Regarding pulmonary thromboembolism, only the patient's age is a risk factor for
pulmonary embolism, as observed in epidemiological studies<sup><xref rid="r03" ref-type="bibr">3</xref></sup>. Moreover, there was no clinical history consistent with
hypercoagulability syndrome with recurrent thrombotic events, although such an
association can only be ruled out after specific laboratory investigation for the most
prevalent types of thrombophilia in the general population, which are factor V Leiden,
hyperhomocysteinemia and antiphospholipid antibody syndrome, in addition to the less
prevalent ones such as antithrombin III, protein C and S deficiency<sup><xref rid="r04" ref-type="bibr">4</xref></sup>.</p>
      <p>Clinical investigation of pulmonary thromboembolism involves echocardiography, perfusion
and ventilation pulmonary scintigraphy, Doppler of lower limbs, pulmonary angiography,
and in some cases, pulmonary arteriography, although in the present case only the
echocardiography was performed. Therefore, there are no data to support this
diagnosis.</p>
      <p>For the differential diagnosis, systemic diseases that have renal and cardiac
involvement (clinical situations that the patient had) were considered, e.g., systemic
lupus erythematosus and schistosomiasis, in addition to hepatic neoplasms which, in this
case, should be considered because of the patient's age, history of weight loss in
recent years and the presence of liver nodules identified by computed tomography.
However, there are no data to confirm this diagnosis.</p>
      <p>Systemic lupus erythematosus can affect both renal and cardiac function and these may
present with heart failure, such as myocarditis and Libman-Sacks endocarditis, but they
do not cause diastolic heart failure, as in this case<sup><xref rid="r05" ref-type="bibr">5</xref></sup>. The high pulmonary artery systolic pressure (65 mmHg)
makes the possibility of constrictive pericarditis caused by lupus even more remote.</p>
      <p>Schistosomiasis is another cause of cardiac and renal involvement, with manifestations
predominantly in the right heart chambers, pulmonary hypertension and even cor
pulmonale<sup><xref rid="r06" ref-type="bibr">6</xref></sup>. The clinical picture
of the patient, with gastrointestinal disorders, portal hypertension, hepatomegaly,
ascites, and marked weight loss contributes to this diagnosis. However, the chronic form
of cor pulmonale consists in a combination of right ventricle hypertrophy and dilation
secondary to pulmonary hypertension, neither of which was identified in the patient.</p>
      <p>As the last and main cause of clinical deterioration of the patient, is the evolution of
the underlying disease itself, in this case, diastolic heart failure with preserved left
ventricular fraction. Diastolic cardiomyopathy is characterized by changes in
ventricular relaxation, with impaired ventricular filling and/or increased filling
pressures and increased dependence on the atrial contraction phase<sup><xref rid="r07" ref-type="bibr">7</xref></sup>. There is an increase in left atrial
pressure and, consequently, in the pulmonary veins and capillaries, as well as a
decrease in stroke volume, signs present in this type of heart disease that explain
exercise intolerance and even dyspnea at rest, referred by the patient. The evidence of
diastolic dysfunction can be obtained from the hemodynamic data, levels of natriuretic
peptides, echocardiographic and tissue Doppler data<sup><xref rid="r08" ref-type="bibr">8</xref></sup>. Among the main causes of left ventricular diastolic dysfunction
are systemic hypertension with left ventricular hypertrophy, aortic stenosis with
preserved left ventricular ejection fraction, hypertrophic and restrictive
cardiomyopathies and coronary artery disease.</p>
      <p>Hypertensive heart disease can be defined as the result of overload imposed to the LV by
the increase in arterial pressure and peripheral vascular resistance, which causes
structural changes in the LV that manifest as hypertrophy and total stiffness<sup><xref rid="r09" ref-type="bibr">9</xref></sup>; however, in this case, the patient did
not have systemic arterial hypertension. As for aortic stenosis, there are no data to
support the diagnosis.</p>
      <p>For the diagnosis of left ventricular hypertrophy, the electrocardiogram (ECG) is not a
sensitive method, but quite specific. Still, the findings of the patient in this case do
not meet these criteria. Echocardiography is a low-cost procedure and is considered the
method of choice for non-invasive diagnosis of increased cardiac mass<sup><xref rid="r10" ref-type="bibr">10</xref></sup>. However, in this case, the patient had
no criteria for hypertrophic cardiomyopathy at the echocardiography.</p>
      <p>One must also emphasize the differential diagnosis between left ventricular hypertrophy
and restrictive cardiomyopathy, especially with the low-voltage electrocardiogram in the
frontal plane, present in the latter cardiomyopathy, which favors the storage disease
and consequent restriction to ventricular filling<sup><xref rid="r11" ref-type="bibr">11</xref></sup>.</p>
      <p>The clinical findings of lower-limb edema and hepatomegaly, as well as the supplementary
tests (electrocardiogram and echocardiogram), pointed to predominant RV involvement with
overload and dilation of both atria and normal LV systolic function and dimensions.
These characteristics corroborate the diagnosis of heart disease with diastolic
restriction. Among the diseases that can cause restrictive cardiomyopathy<sup><xref rid="r12" ref-type="bibr">12</xref></sup> are storage diseases (hemochromatosis
and Fabry disease), endomyocardial disease (endomyocardial fibrosis) and infiltrative
diseases (amyloidosis and sarcoidosis).</p>
      <p>Hemochromatosis is characterized by excessive iron deposits on parenchymal tissues
(heart, liver, gonads, and pancreas). It can occur as an autosomal recessive or
idiopathic disorder, in association with defects in hemoglobin synthesis due to
ineffective erythropoiesis, chronic liver disease and excessive oral ingestion or
parenteral administration of iron for many years<sup><xref rid="r13" ref-type="bibr">13</xref></sup>.</p>
      <p>Cardiac involvement leads to the combined pattern of dilated cardiomyopathy and
restrictive cardiomyopathy with systolic and diastolic dysfunction. Myocardial damage is
mainly attributed to direct toxicity of free iron and not only the tissue infiltration.
Cardiac dilatation occurs with increased ventricular thickness. The findings are more
prominent in ventricular than in atrial myocardium and it often affects the cardiac
conduction system. In this patient, although he showed increased ventricular thickness
demonstrated by the echocardiography, there was no ventricular dilatation or systemic
manifestations of the disease, making this hypothesis unlikely.</p>
      <p>Fabry disease is a genetic disorder with X-linked recessive inheritance, resulting from
abnormalities linked to the deficiency of the lysosomal enzyme alpha-galactosidase A,
which is caused by more than 160 mutations<sup><xref rid="r14" ref-type="bibr">14</xref></sup>. Some of them result in undetectable enzyme activity, which manifest
throughout the body, while others produce some degree of enzymatic activity resulting in
variants with limited involvement only in the myocardium. The disease is characterized
by an intracellular accumulation of glycosphingolipids with marked involvement of the
skin, kidneys and myocardium in the classic form. Involvement of the vascular
endothelium occurs, as well as of conduction tissue and heart valves, particularly the
mitral valve.</p>
      <p>The major clinical manifestations result from the accumulation of glycosphingolipids in
cell endothelium, with eventual occlusion of small arterioles. Angina pectoris and
myocardial infarction occur, although in most cases, the coronary arteries have normal
angiographic aspect. There is thickening of the left ventricle, producing usually mild
diastolic dysfunction, with preserved systolic function and mitral regurgitation without
clinical significance. The symptomatic cardiovascular involvement occurs in nearly all
male patients, whereas the symptoms are mild or absent in females. The following are
common findings: arterial hypertension, mitral valve prolapse and congestive heart
failure. The patient of the present case had no skin manifestations, systemic arterial
hypertension, or acute myocardial ischemia.</p>
      <p>Endomyocardial fibrosis, common in tropical countries, most often occurs in children and
young adults. It is characterized by endocardial fibrosis of the inflow tract of one or
both ventricles. Biventricular disease occurs in almost half the cases; 40% of them have
isolated involvement in the left ventricle and 10%, isolated impairment of the right
ventricle<sup><xref rid="r13" ref-type="bibr">13</xref>,<xref rid="r15" ref-type="bibr">15</xref></sup>. There is an irregular association with eosinophilia. LV
impairment results in pulmonary congestion symptoms, while RV involvement may show
characteristics of restrictive cardiomyopathy and also simulate constrictive
pericarditis. Failure of one or both atrioventricular valves often occurs<sup><xref rid="r16" ref-type="bibr">16</xref></sup>.</p>
      <p>Electrocardiographic and echocardiographic findings include: decreased QRS complex
voltage, pericardial effusion, apical obliteration and increased endocardial echo
reflectivity<sup><xref rid="r15" ref-type="bibr">15</xref></sup>. The latter
findings were not confirmed in this clinical case and, moreover, the endomyocardial
fibrosis does not explain thyroid and renal involvement shown by the patient.</p>
      <p>Being one of the causes of restrictive cardiomyopathy, sarcoidosis is a systemic
granulomatous disease of unknown etiology, characterized by the involvement of various
tissues by noncaseating granulomas<sup><xref rid="r17" ref-type="bibr">17</xref></sup>.</p>
      <p>Cardiac involvement is infrequent and primary clinical manifestations occur in less than
5% of patients, being characterized by conduction defects, ventricular arrhythmias,
syncope and sudden death. The direct myocardial involvement by granulomas and scar
tissue can manifest as dilated or restrictive cardiomyopathy, with progressive
course<sup><xref rid="r18" ref-type="bibr">18</xref></sup>. The ECG is nonspecific
and can show T wave abnormalities, blocks or pathological Q waves. Other findings
include pericarditis and cor pulmonale. Echocardiography can disclose thinning of the
ventricular wall and increased echogenicity<sup><xref rid="r18" ref-type="bibr">18</xref></sup>. Cardiac magnetic resonance is a highly sensitive and specific
method for diagnosis. In our case, there were no suggestive alterations, making it
unlikely that this was the patient's diagnosis.</p>
      <p>And finally, systemic amyloidosis, which is a group of diseases that have extracellular
deposits of insoluble fibrillar proteins consisting of low molecular weight
subunits<sup><xref rid="r05" ref-type="bibr">5</xref></sup>. Clinically, it is
classified as<sup><xref rid="r05" ref-type="bibr">5</xref></sup>: primary (AL),
secondary (AA), hereditary and associated with old age (senile). AL amyloidosis is
caused by the deposition of proteins derived from light chain fragments, in general, a
monoclonal immunoglobulin (80.0% of cases). It may occur alone or in association with
multiple myeloma (10.0% of cases). AA amyloidosis can complicate chronic diseases that
course with recurrent inflammation. The fibrils consist of fragments of amyloid protein
A, an acute phase protein.</p>
      <p>There is also a hereditary-type amyloidosis (deposition of fibrils derived from
transthyretin) and a senile form (also deposition of transthyretin). In this context,
there can be amyloid infiltration in the thyroid, leading to hypothyroidism<sup><xref rid="r19" ref-type="bibr">19</xref></sup>; however, it most commonly occurs
concomitantly with goiter, not described in the case. Another clinical manifestation,
such as autonomic neuropathy due to amyloidosis<sup><xref rid="r05" ref-type="bibr">5</xref></sup>, which courses with orthostatic hypotension, early satiety, change
in bowel habits (diarrhea or chronic constipation) were observed in this patient.</p>
      <p>AA amyloidosis affects the cardiovascular system in only 5% of cases and there is no
mention of systemic inflammation (although serology for hepatitis are not
available)<sup><xref rid="r20" ref-type="bibr">20</xref></sup>. Therefore, the two
subtypes of amyloidosis most likely in this case would be AL and senile amyloidosis.
There are important differences in the prognosis and rate of evolution between these
subtypes: the median survival after cardiac involvement is, respectively, 11 and 75
months<sup><xref rid="r21" ref-type="bibr">21</xref></sup>.</p>
      <p>Furthermore, the insidious course of the disease is the rule for senile amyloidosis,
whereas in AL, there is a rapid progression of symptoms and much higher cardiovascular
involvement. In the absence of confirmation of plasma cell dyscrasia, the distinction
between them is made through immunohistochemical analysis<sup><xref rid="r22" ref-type="bibr">22</xref></sup>.</p>
      <p>Cardiac involvement in cases of amyloidosis occurs in one third of patients. Right
ventricular failure usually occurs, with little pulmonary edema, despite elevated
filling pressures. There are, however, other alterations including atrial fibrillation,
conduction disorders and electrically inactive areas. Still, high-grade atrioventricular
blocks are uncommon<sup><xref rid="r11" ref-type="bibr">11</xref></sup>.
Echocardiography is an important noninvasive test for the diagnosis of amyloidosis. LV
wall thickening with evidence of diastolic dysfunction is the earliest alteration, which
can progress to restrictive cardiomyopathy<sup><xref rid="r23" ref-type="bibr">23</xref></sup>. Biatrial enlargement and valve thickening may occur<sup><xref rid="r19" ref-type="bibr">19</xref></sup>.</p>
      <p>The diagnostic investigation includes collecting a urine sample to test for the presence
of paraproteins. The detection of increased excretion of light chains with maintenance
of the kappa/lambda ratio, in the absence of the monoclonal chain establishes the
diagnosis of amyloidosis<sup><xref rid="r20" ref-type="bibr">20</xref></sup>. Although
not confirmed by tests, the diagnosis of amyloidosis can be achieved through a
biopsy<sup><xref rid="r24" ref-type="bibr">24</xref></sup>, which can be performed
in subcutaneous adipose tissue (sensitivity of 65 to 80%)<sup><xref rid="r25" ref-type="bibr">25</xref></sup> or in the endomyocardium (up to 97%)<sup><xref rid="r26" ref-type="bibr">26</xref></sup>with demonstration of amyloid deposits in
tissues classically stained with Congo red. Therefore, due to the clinical picture of
the patient and the complementary tests described, systemic amyloidosis is the most
likely diagnosis of this anatomo clinical discussion.</p>
      <p>There was not enough time to evaluate the hepatic findings in the abdominal ultrasound,
which may have contributed to the case outcome. (Dr. Tiago Rodrigues Politi)</p>
      <sec>
        <title>Diagnostic hypothesis</title>
        <p>Systemic amyloidosis with cardiac and renal involvement.</p>
        <p>Other diagnoses: hypothyroidism and chronic renal failure. (<bold>Dr. Tiago Rodrigues
Politi</bold>)</p>
      </sec>
      <sec>
        <title>Necropsy</title>
        <p>The patient had cachexia. The final factor triggering his death was pulmonary
embolism in the lower lobe of the left lung. There was infarction in this territory
(<xref ref-type="fig" rid="f03">Figure 3</xref>) and acute infection in this and
other areas of the lungs. Pulmonary thromboembolism was probably secondary to a
clotting disorder, as, in addition to it, there was portal vein thrombosis and
presence of thrombi that seemed to be recent (i.e., onset in the agonal period) in
coronary arterial branches.</p>
        <fig id="f03" orientation="portrait" position="float">
          <label>Figure 3</label>
          <caption>
            <p>Histological section of the lower lobe of the left lung with infarction,
characterized by destruction of alveolar septa, of which there are only
remnants of elastic tissue (yellow arrows). This tissue appears more intact
around the small vessels (blue arrows). Verhoeff staining, magnification:
10x.</p>
          </caption>
          <graphic xlink:href="abc-101-05-0e86-g03"/>
        </fig>
        <p>The main disease of this patient was hepatocellular carcinoma (<xref ref-type="fig" rid="f04">Figure 4</xref>), underlying chronic hepatitis (<xref ref-type="fig" rid="f05">Figure 5</xref>). The neoplasm is the likely cause of the bleeding
disorder.</p>
        <fig id="f04" orientation="portrait" position="float">
          <label>Figure 4</label>
          <caption>
            <p>Histological section of the liver showing with hepatocarcinoma nodules
consisting of cell cords (arrows), with the non-neoplastic tissue in the
center, of more intense color and approximately stellar shape. Hematoxylin and
eosin staining; magnification: 5x.</p>
          </caption>
          <graphic xlink:href="abc-101-05-0e86-g04"/>
        </fig>
        <fig id="f05" orientation="portrait" position="float">
          <label>Figure 5</label>
          <caption>
            <p>Histological section of the liver showing the formation of cirrhotic nodules,
with darker borders. Masson staining; magnification: 5x.</p>
          </caption>
          <graphic xlink:href="abc-101-05-0e86-g05"/>
        </fig>
        <p>In addition to this disease, the patient also had cardiomyopathy, of which
predominant clinical picture was atrial fibrillation (which can also be related to
pulmonary thromboembolism, but there were no thrombi in the cardiac cavities). The
fact that the ventricles did not show marked dilation, contrary to what happens with
the atria (<xref ref-type="fig" rid="f06">Figure 6</xref>), suggests that it is a
case of restrictive cardiomyopathy. Among its possible causes are: amyloidosis,
hypertrophic cardiomyopathy and ischemic heart disease. However, the absence of
amorphous extracellular deposits, myocardial fiber disarray and severe obstruction of
the coronary arteries go against such possibilities. Thus, the idiopathic form, with
interstitial fibrosis, should be considered.</p>
        <fig id="f06" orientation="portrait" position="float">
          <label>Figure 6</label>
          <caption>
            <p>Posterior face of the heart. The double line roughly highlights the
atrioventricular groove. Note the large atrial dilation, of which height equals
or even surpasses that of the ventricles.</p>
          </caption>
          <graphic xlink:href="abc-101-05-0e86-g06"/>
        </fig>
        <p>The patient also had atherosclerosis, with mild aortic and mild to moderate
involvement of the coronary tree, but with no significant consequences. The kidneys
had some degree of vascular alterations, which may be associated with
atherosclerosis; kidney failure may have been associated with hepatorenal
syndrome.</p>
        <p>
          <bold>(Dr. Paulo Sampaio Gutierrez)</bold>
        </p>
      </sec>
      <sec>
        <title>Anatomopathological diagnosis</title>
        <p><bold>Main disease:</bold> hepatocellular carcinoma related to chronic hepatitis,
probably viral.</p>
        <p><bold>Relevant secondary disease:</bold> restrictive cardiomyopathy.</p>
        <p><bold>Cause of death:</bold> pulmonary thromboembolism (<bold>Dr. Paulo Sampaio
Gutierrez</bold>)</p>
      </sec>
    </sec>
    <sec>
      <title>Comment</title>
      <p>It is difficult in this case, to be sure that the pulmonary embolism, which was the
final factor triggering death, was more related to heart failure or, as it seems likely,
considering that such picture was well balanced and that there were no intracavitary
thrombi, to hepatocellular carcinoma.</p>
      <p>It is noteworthy the lack of a cancer diagnosis during the patient's life, corroborating
data indicating that autopsies still currently disclose important diagnoses in a
significant number of patients with heart disease<sup><xref rid="r27" ref-type="bibr">27</xref></sup>.</p>
      <p>Regarding the heart disease, amyloidosis is a possibility that should be considered in
heart failure with restrictive pattern in the elderly. However, the clinical profile of
patients with restrictive idiopathic cardiomyopathy<sup><xref rid="r28" ref-type="bibr">28</xref></sup> showed age variation of 10-90 years, with a mean of 64.
Therefore, the patient fits into this description, not only regarding age but also
concerning the atrial fibrillation, detected in 74% of patients. <bold>(Dr. Paulo
Sampaio Gutierrez)</bold></p>
      <p><bold>Section Editor:</bold> Alfredo Jos&#xE9; Mansur
(<email>ajmansur@incor.usp.br</email>)</p>
      <p><bold>Associate Editors:</bold> Desid&#xE9;rio Favarato
(<email>dclfavarato@incor.usp.br</email>)</p>
      <p>Vera Demarchi Aiello (<email>anpvera@incor.usp.br</email>)</p>
    </sec>
  </body>
  <back>
    <ref-list>
      <title>References</title>
      <ref id="r01">
        <label>1</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Roberts</surname>
              <given-names>WC</given-names>
            </name>
            <name>
              <surname>Gardin</surname>
              <given-names>JM</given-names>
            </name>
          </person-group>
          <article-title>Location of myocardial infarcts: a confusion of terms and
definitions</article-title>
          <source>Am J Cardiol</source>
          <year>1978</year>
          <volume>42</volume>
          <issue>5</issue>
          <fpage>868</fpage>
          <lpage>872</lpage>
          <pub-id pub-id-type="pmid">707300</pub-id>
        </element-citation>
      </ref>
      <ref id="r02">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Uddin</surname>
              <given-names>SN</given-names>
            </name>
            <name>
              <surname>Begum</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Malik</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Rahman</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Coronary artery disease in young patients: clinical review and risk
facto analysis</article-title>
          <source>Mimensingh Med J</source>
          <year>2003</year>
          <volume>12</volume>
          <issue>1</issue>
          <fpage>3</fpage>
          <lpage>7</lpage>
        </element-citation>
      </ref>
      <ref id="r03">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Goldhaber</surname>
              <given-names>SZ</given-names>
            </name>
          </person-group>
          <article-title>Pulmonary embolism</article-title>
          <source>N Engl J Med</source>
          <year>1998</year>
          <volume>339</volume>
          <issue>2</issue>
          <fpage>93</fpage>
          <lpage>104</lpage>
          <pub-id pub-id-type="pmid">9654541</pub-id>
        </element-citation>
      </ref>
      <ref id="r04">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Fedulo</surname>
              <given-names>PF</given-names>
            </name>
            <name>
              <surname>Auger</surname>
              <given-names>WR</given-names>
            </name>
            <name>
              <surname>Kerr</surname>
              <given-names>KM</given-names>
            </name>
            <name>
              <surname>Rubin</surname>
              <given-names>LJ</given-names>
            </name>
          </person-group>
          <article-title>Chronic thromboembolic pulmonary hypertesion</article-title>
          <source>N Engl J Med</source>
          <year>2001</year>
          <volume>345</volume>
          <issue>20</issue>
          <fpage>1465</fpage>
          <lpage>1472</lpage>
          <pub-id pub-id-type="pmid">11794196</pub-id>
        </element-citation>
      </ref>
      <ref id="r05">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Dember</surname>
              <given-names>LM</given-names>
            </name>
            <name>
              <surname>Shepard</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Nesta</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Stone</surname>
              <given-names>JR</given-names>
            </name>
          </person-group>
          <article-title>Case records of the Massachusetts General Hospital. Case 15-2005 - An
80-year-old man with shortness of breath, edema, and proteinuria</article-title>
          <source>N Engl J Med</source>
          <year>2005</year>
          <volume>352</volume>
          <issue>20</issue>
          <fpage>2111</fpage>
          <lpage>2119</lpage>
          <pub-id pub-id-type="pmid">15901865</pub-id>
        </element-citation>
      </ref>
      <ref id="r06">
        <label>6</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Barbosa</surname>
              <given-names>MM</given-names>
            </name>
            <name>
              <surname>Lamounier</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Lambertucci</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Cardiopulmonary involvement in schistosomiasis</article-title>
          <source>Arq Bras Cardiol</source>
          <year>1995</year>
          <volume>65</volume>
          <issue>4</issue>
          <fpage>343</fpage>
          <lpage>348</lpage>
          <pub-id pub-id-type="pmid">8728810</pub-id>
        </element-citation>
      </ref>
      <ref id="r07">
        <label>7</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Aurigemma</surname>
              <given-names>GP</given-names>
            </name>
            <name>
              <surname>Gaasch</surname>
              <given-names>WH</given-names>
            </name>
          </person-group>
          <article-title>Clinical practice: diastolic heart failure</article-title>
          <source>N Engl J Med</source>
          <year>2004</year>
          <volume>351</volume>
          <issue>11</issue>
          <fpage>1097</fpage>
          <lpage>1105</lpage>
          <pub-id pub-id-type="pmid">15356307</pub-id>
        </element-citation>
      </ref>
      <ref id="r08">
        <label>8</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bocchi</surname>
              <given-names>EA</given-names>
            </name>
            <name>
              <surname>Marcondes-Braga</surname>
              <given-names>FG</given-names>
            </name>
            <name>
              <surname>Ayub-Ferreira</surname>
              <given-names>SM</given-names>
            </name>
            <name>
              <surname>Rohde</surname>
              <given-names>LE</given-names>
            </name>
            <name>
              <surname>Oliveira</surname>
              <given-names>WA</given-names>
            </name>
            <name>
              <surname>Almeida</surname>
              <given-names>DR</given-names>
            </name>
            <etal>et al</etal>
            <collab>Sociedade Brasileira de Cardiologia</collab>
          </person-group>
          <article-title xml:lang="pt">III Diretriz brasileira de insufici&#xEA;ncia card&#xED;aca
cr&#xF4;nica</article-title>
          <source>Arq Bras Cardiol</source>
          <year>2009</year>
          <volume>92</volume>
          <issue>1</issue>
          <supplement>supl.1</supplement>
          <fpage>1</fpage>
          <lpage>71</lpage>
        </element-citation>
      </ref>
      <ref id="r09">
        <label>9</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Dunn</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Pfeffer</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Left ventricular hypertrophy in hypertension</article-title>
          <source>N Engl J Med</source>
          <year>1999</year>
          <volume>340</volume>
          <issue>16</issue>
          <fpage>1270</fpage>
          <lpage>1280</lpage>
        </element-citation>
      </ref>
      <ref id="r10">
        <label>10</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Messerli</surname>
              <given-names>FH</given-names>
            </name>
          </person-group>
          <article-title>Left ventricular hypertrophy, arterial hypertension and sudden
death</article-title>
          <source>J Hypertens</source>
          <year>1990</year>
          <volume>8</volume>
          <issue>7</issue>
          <fpage>S181</fpage>
          <lpage>S186</lpage>
        </element-citation>
      </ref>
      <ref id="r11">
        <label>11</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Murtagh</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Hammill</surname>
              <given-names>SC</given-names>
            </name>
            <name>
              <surname>Gertz</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Kyle</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Tajik</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Grogan</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Electrocardiographic findings in primary systemic amyloidosis and
biopsy-proven cardiac involvement</article-title>
          <source>Am J Cardiol</source>
          <year>2005</year>
          <volume>95</volume>
          <issue>4</issue>
          <fpage>535</fpage>
          <lpage>537</lpage>
          <pub-id pub-id-type="pmid">15695149</pub-id>
        </element-citation>
      </ref>
      <ref id="r12">
        <label>12</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kuperstein</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Feinberg</surname>
              <given-names>MS</given-names>
            </name>
            <name>
              <surname>Rosenblat</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Beker</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Eldar</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Schwammenthal</surname>
              <given-names>E</given-names>
            </name>
          </person-group>
          <article-title>Prevalence, etiology, and outcome of patients with restrictive left
ventricular filling and relatively preserved systolic function</article-title>
          <source>Am J Cardiol</source>
          <year>2003</year>
          <volume>91</volume>
          <issue>12</issue>
          <fpage>1517</fpage>
          <lpage>1519</lpage>
          <pub-id pub-id-type="pmid">12804751</pub-id>
        </element-citation>
      </ref>
      <ref id="r13">
        <label>13</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hoffbrand</surname>
              <given-names>AV</given-names>
            </name>
          </person-group>
          <article-title>Diagnosing myocardial iron overload</article-title>
          <source>Eur Heart J</source>
          <year>2001</year>
          <volume>22</volume>
          <issue>23</issue>
          <fpage>2140</fpage>
          <lpage>2141</lpage>
          <pub-id pub-id-type="pmid">11913473</pub-id>
        </element-citation>
      </ref>
      <ref id="r14">
        <label>14</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Frustaci</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Chimenti</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Ricci</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Natale</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Russo</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Pieroni</surname>
              <given-names>M</given-names>
            </name>
            <etal>et al</etal>
          </person-group>
          <article-title>Improvement in cardiac function in the cardiac variant of Fabry&#xB4;s
disease with galactose-infusion therapy</article-title>
          <source>N Engl J Med</source>
          <year>2001</year>
          <volume>345</volume>
          <issue>1</issue>
          <fpage>25</fpage>
          <lpage>32</lpage>
          <pub-id pub-id-type="pmid">11439944</pub-id>
        </element-citation>
      </ref>
      <ref id="r15">
        <label>15</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Berensztein</surname>
              <given-names>CS</given-names>
            </name>
            <name>
              <surname>Pineiro</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Marcotegui</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Brunoldi</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Blanco</surname>
              <given-names>MV</given-names>
            </name>
            <name>
              <surname>Lerman</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Usefulness of echocardiography and Doppler echocardiography in
endomyocardial fibrosis</article-title>
          <source>J Am Soc Echocardiogr</source>
          <year>2000</year>
          <volume>13</volume>
          <issue>5</issue>
          <fpage>385</fpage>
          <lpage>392</lpage>
          <pub-id pub-id-type="pmid">10804436</pub-id>
        </element-citation>
      </ref>
      <ref id="r16">
        <label>16</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Barretto</surname>
              <given-names>AC</given-names>
            </name>
            <name>
              <surname>Mady</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Oliveira</surname>
              <given-names>SA</given-names>
            </name>
            <name>
              <surname>Arteaga</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Dal Bo</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Ramires</surname>
              <given-names>JA</given-names>
            </name>
          </person-group>
          <article-title>Clinical meaning of ascites in patients with endomyocardial
fibrosis</article-title>
          <source>Arq Bras Cardiol</source>
          <year>2002</year>
          <volume>78</volume>
          <issue>2</issue>
          <fpage>196</fpage>
          <lpage>199</lpage>
          <pub-id pub-id-type="pmid">11887195</pub-id>
        </element-citation>
      </ref>
      <ref id="r17">
        <label>17</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sharma</surname>
              <given-names>OP</given-names>
            </name>
          </person-group>
          <article-title>Diagnosis of cardiac sarcoidosis: an imperfect science, a hesitant
art</article-title>
          <source>Chest</source>
          <year>2003</year>
          <volume>123</volume>
          <issue>1</issue>
          <fpage>18</fpage>
          <lpage>19</lpage>
          <pub-id pub-id-type="pmid">12527597</pub-id>
        </element-citation>
      </ref>
      <ref id="r18">
        <label>18</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yazaki</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Isobe</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Hiramitsu</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Morimoto</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Hiroe</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Omichi</surname>
              <given-names>C</given-names>
            </name>
            <etal>et al</etal>
          </person-group>
          <article-title>Comparison of clinical features and prognosis of cardiac sarcoidosis
and idiopathic dilated cardiomyopathy</article-title>
          <source>Am J Cardiol</source>
          <year>1998</year>
          <volume>82</volume>
          <issue>4</issue>
          <fpage>537</fpage>
          <lpage>540</lpage>
          <pub-id pub-id-type="pmid">9723651</pub-id>
        </element-citation>
      </ref>
      <ref id="r19">
        <label>19</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kimura</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Yamashita</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Ashizawa</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Yokoyama</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Naga-taki</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Thyroid disfunction in patients with amyloid goiter</article-title>
          <source>Clin Endocrinol</source>
          <year>1997</year>
          <volume>46</volume>
          <issue>6</issue>
          <fpage>769</fpage>
          <lpage>774</lpage>
        </element-citation>
      </ref>
      <ref id="r20">
        <label>20</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lachmann</surname>
              <given-names>HJ</given-names>
            </name>
            <name>
              <surname>Gallimore</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Gillmore</surname>
              <given-names>JD</given-names>
            </name>
            <name>
              <surname>Carr-Smith</surname>
              <given-names>HD</given-names>
            </name>
            <name>
              <surname>Bradwell</surname>
              <given-names>AR</given-names>
            </name>
            <name>
              <surname>Pepys</surname>
              <given-names>MB</given-names>
            </name>
            <etal>et al</etal>
          </person-group>
          <article-title>Outcome in systemic AL amyloidosis in relation to changes in
concentration of circulating free immunoglobulin light chains following
chemotherapy</article-title>
          <source>Br J Haematol</source>
          <year>2003</year>
          <volume>122</volume>
          <issue>1</issue>
          <fpage>78</fpage>
          <lpage>84</lpage>
          <pub-id pub-id-type="pmid">12823348</pub-id>
        </element-citation>
      </ref>
      <ref id="r21">
        <label>21</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Arbustini</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Morbini</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Verga</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Concardi</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Porcu</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Pilotto</surname>
              <given-names>A</given-names>
            </name>
            <etal>et al</etal>
          </person-group>
          <article-title>Light and electron microscopy immunohistochemical characterization of
amyloid deposits</article-title>
          <source>Amyloid</source>
          <year>1997</year>
          <volume>4</volume>
          <issue>3</issue>
          <fpage>157</fpage>
          <lpage>170</lpage>
        </element-citation>
      </ref>
      <ref id="r22">
        <label>22</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ng</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Connors</surname>
              <given-names>LH</given-names>
            </name>
            <name>
              <surname>Davidoff</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Skinner</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Falk</surname>
              <given-names>RH</given-names>
            </name>
          </person-group>
          <article-title>Senile systemic amyloidosis presenting with heart failure: a
comparison with light chain-associated amyloidosis</article-title>
          <source>Arch Intern Med</source>
          <year>2005</year>
          <volume>165</volume>
          <issue>12</issue>
          <fpage>1425</fpage>
          <lpage>1429</lpage>
          <pub-id pub-id-type="pmid">15983293</pub-id>
        </element-citation>
      </ref>
      <ref id="r23">
        <label>23</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Klein</surname>
              <given-names>AL</given-names>
            </name>
            <name>
              <surname>Hatle</surname>
              <given-names>LK</given-names>
            </name>
            <name>
              <surname>Burstow</surname>
              <given-names>DJ</given-names>
            </name>
            <name>
              <surname>Taliercio</surname>
              <given-names>CP</given-names>
            </name>
            <name>
              <surname>Seward</surname>
              <given-names>JB</given-names>
            </name>
            <name>
              <surname>Kyle</surname>
              <given-names>RA</given-names>
            </name>
            <etal>et al</etal>
          </person-group>
          <article-title>Comprehensive Doppler assessment of right ventricular diastolic
function in cardiac amyloidosis</article-title>
          <source>J Am Coll Cardiol</source>
          <year>1990</year>
          <volume>15</volume>
          <issue>1</issue>
          <fpage>99</fpage>
          <lpage>108</lpage>
          <pub-id pub-id-type="pmid">2295749</pub-id>
        </element-citation>
      </ref>
      <ref id="r24">
        <label>24</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Swan</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Skinner</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>O'Hara</surname>
              <given-names>CJ</given-names>
            </name>
          </person-group>
          <article-title>Bone marrow core biopsy specimens in AL (primary) amyloidosis: a
morphologic and immunohistochemical study of 100 cases</article-title>
          <source>Am J Clin Pathol</source>
          <year>2003</year>
          <volume>120</volume>
          <issue>4</issue>
          <fpage>610</fpage>
          <lpage>616</lpage>
          <pub-id pub-id-type="pmid">14560572</pub-id>
        </element-citation>
      </ref>
      <ref id="r25">
        <label>25</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Andrews</surname>
              <given-names>TR</given-names>
            </name>
            <name>
              <surname>Colon-Otero</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Calamia</surname>
              <given-names>KT</given-names>
            </name>
            <name>
              <surname>Menkes</surname>
              <given-names>DM</given-names>
            </name>
            <name>
              <surname>Boylan</surname>
              <given-names>KB</given-names>
            </name>
            <name>
              <surname>Kyle</surname>
              <given-names>RA</given-names>
            </name>
          </person-group>
          <article-title>Utility of subcutaneous fat aspiration for diagnosing amyloidosis in
patients with isolated peripheral neuropathy</article-title>
          <source>Mayo Clin Proc</source>
          <year>2002</year>
          <volume>77</volume>
          <issue>12</issue>
          <fpage>1287</fpage>
          <lpage>1290</lpage>
          <pub-id pub-id-type="pmid">12479513</pub-id>
        </element-citation>
      </ref>
      <ref id="r26">
        <label>26</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pellikka</surname>
              <given-names>PA</given-names>
            </name>
            <name>
              <surname>Holmes</surname>
              <given-names>DR</given-names>
              <suffix>Jr</suffix>
            </name>
            <name>
              <surname>Edwards</surname>
              <given-names>WD</given-names>
            </name>
            <name>
              <surname>Nishimura</surname>
              <given-names>RA</given-names>
            </name>
            <name>
              <surname>Tajik</surname>
              <given-names>AJ</given-names>
            </name>
            <name>
              <surname>Kyle</surname>
              <given-names>RA</given-names>
            </name>
          </person-group>
          <article-title>Endomyocardial biopsy in 30 patients with primary amyloidosis and
suspected cardiac involvement</article-title>
          <source>Arch Intern Med</source>
          <year>1988</year>
          <volume>148</volume>
          <issue>3</issue>
          <fpage>662</fpage>
          <lpage>666</lpage>
          <pub-id pub-id-type="pmid">3341867</pub-id>
        </element-citation>
      </ref>
      <ref id="r27">
        <label>27</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Saad</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Yamada</surname>
              <given-names>AT</given-names>
            </name>
            <name>
              <surname>Pereira da Rosa</surname>
              <given-names>FH</given-names>
            </name>
            <name>
              <surname>Gutierrez</surname>
              <given-names>PS</given-names>
            </name>
            <name>
              <surname>Mansur</surname>
              <given-names>AJ</given-names>
            </name>
          </person-group>
          <article-title>Comparison between clinical and autopsy diagnoses in a Cardiology
hospital</article-title>
          <source>Heart</source>
          <year>2007</year>
          <volume>93</volume>
          <issue>11</issue>
          <fpage>1414</fpage>
          <lpage>1419</lpage>
          <pub-id pub-id-type="pmid">17395672</pub-id>
        </element-citation>
      </ref>
      <ref id="r28">
        <label>28</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ammash</surname>
              <given-names>NM</given-names>
            </name>
            <name>
              <surname>Seward</surname>
              <given-names>JB</given-names>
            </name>
            <name>
              <surname>Bailey</surname>
              <given-names>KR</given-names>
            </name>
            <name>
              <surname>Edwards</surname>
              <given-names>WD</given-names>
            </name>
            <name>
              <surname>Tajik</surname>
              <given-names>AJ</given-names>
            </name>
          </person-group>
          <article-title>Clinical profile and outcome of idiopathic restrictive
cardiomyopathy</article-title>
          <source>Circulation</source>
          <year>2000</year>
          <volume>101</volume>
          <issue>21</issue>
          <fpage>2490</fpage>
          <lpage>2496</lpage>
          <pub-id pub-id-type="pmid">10831523</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
